자동화 NGS 라이브러리 조제 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 유형별, 워크플로우별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Automated NGS Library Preparation Market Summary

The global automated NGS library preparation market size was estimated at USD 777.2 million in 2025 and is projected to reach 2.1 billion in 2033, growing at a CAGR of 13.2% from 2026 to 2033. Growth is driven by rising demand for genomic research, increased adoption of high-throughput sequencing, and the shift toward automated, efficient, and reproducible workflows supported by bioinformatics advancements.

Automation as a Catalyst in NGS Workflow Transformation

The integration of automation in next-generation sequencing (NGS) library preparation is transforming public health and clinical diagnostics by reducing human error, improving consistency, and enabling higher throughput. These advantages are particularly valuable in time-sensitive and resource-constrained settings, which have accelerated demand for scalable sequencing infrastructure and automated workflows. Technologies such as automated liquid handlers and modular platforms streamline complex processes, including magnetic bead purification and enzymatic fragmentation, thereby supporting broader adoption of advanced molecular diagnostics. To capitalize on this trend, several key players have developed fully automated library preparation platforms, as shown in the figure below.

As sequencing applications expand beyond research into clinical and epidemiological use, the role of automated library preparation becomes even more critical. The ability to process large sample volumes with minimal variability ensures reproducibility and data quality, which are essential for diagnostics, surveillance, and personalized medicine. Automation enhances efficiency while supporting the scalability needed for population-level genomics, reinforcing its growing value across academic, commercial, and public health laboratories.

Advancements In Automation And Robotics

The shift toward automation in NGS library preparation is fundamentally altering how laboratories manage scale, efficiency, and cost. Automated platforms now handle complex, multi-step protocols, from nucleic acid extraction to adapter ligation, with minimal manual intervention. This reduces turnaround times and operational burden, allowing labs to reassign skilled personnel to more analytical or interpretative roles. As demand for high-throughput sequencing in clinical and translational research grows, automation becomes a strategic imperative rather than a technical upgrade.

Moreover, automated systems are increasingly modular and adaptable, supporting diverse sample types and sequencing protocols. This flexibility allows institutions to future-proof their investments, align with evolving research priorities, and meet the rising expectations of data quality and reproducibility in modern genomics.

Global Automated NGS Library Preparation Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global automated NGS library preparation market based on product, type, workflow, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Kits & Reagents
  • DNA Library Preparation Kits
  • RNA Library Preparation Kits
  • Exome/Targeted Capture Library Preparation Kits
  • Others
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Targeted Genome Sequencing
• Whole Genome Sequencing
• Whole Exome Sequencing
• Other Sequencing Types
• Workflow Outlook (Revenue, USD Million, 2021 - 2033)
• Nucleic Acid Extraction
• Fragmentation
• Adapter Ligation
• Purification & Quantification
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Drug & Biomarker Discovery
• Disease Diagnostics
  • Cancer Diagnostics
  • Reproductive Health Diagnostics
  • Infectious Disease Diagnostics
  • Other Disease Diagnostic Applications
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Workflow
  • 1.2.4. Application
  • 1.2.5. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Automation as a Catalyst in NGS Workflow Transformation
    • 3.2.1.2. Advancements in Automation and Robotics
    • 3.2.1.3. Rising Demand for High-Throughput Sequencing
    • 3.2.1.4. Expansion of Precision Medicine and Clinical Diagnostics
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High Cost of Automation Systems
    • 3.2.2.2. Complexity of Workflow Integration
  • 3.2.3. Market Opportunities Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Case Studies Insights
• 3.4. Automated NGS Library Preparation Market: Swot Analysis
• 3.5. Automated NGS Library Preparation Market: Porter's Five Forces Analysis

Chapter 4. Automated NGS Library Preparation Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Automated NGS Library Preparation Market Product Movement Analysis
• 4.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 4.5. Kits & Reagents
  • 4.5.1. Kits & Reagents Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
  • 4.5.2. DNA Library Preparation Kits
    • 4.5.2.1. DNA Library Preparation Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. RNA Library Preparation Kits
    • 4.5.3.1. RNA Library Preparation Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. Exome/Targeted Capture Library Preparation Kits
    • 4.5.4.1. Exome/Targeted Capture Library Preparation Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Automated NGS Library Preparation Market: Type Estimates & Trend Analysis

• 5.1. Type Segment Dashboard
• 5.2. Global Automated NGS Library Preparation Market Type Movement Analysis
• 5.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by Type, 2021 - 2033 (USD Million)
• 5.4. Targeted Genome Sequencing
  • 5.4.1. Targeted Genome Sequencing Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 5.5. Whole Genome Sequencing
  • 5.5.1. Whole Genome Sequencing Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 5.6. Whole Exome Sequencing
  • 5.6.1. Whole Exome Sequencing Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 5.7. Other Sequencing Types
  • 5.7.1. Other Sequencing Types Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)

Chapter 6. Automated NGS Library Preparation Market: Workflow Estimates & Trend Analysis

• 6.1. Workflow Segment Dashboard
• 6.2. Global Automated NGS Library Preparation Market Workflow Movement Analysis
• 6.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by Workflow, 2021 - 2033 (USD Million)
• 6.4. Nucleic Acid Extraction
  • 6.4.1. Nucleic Acid Extraction Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 6.5. Fragmentation
  • 6.5.1. Fragmentation Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 6.6. Adapter Ligation
  • 6.6.1. Adapter Ligation Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 6.7. Purification & Quantification
  • 6.7.1. Purification & Quantification Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)

Chapter 7. Automated NGS Library Preparation Market: Application Estimates & Trend Analysis

• 7.1. Application Segment Dashboard
• 7.2. Global Automated NGS Library Preparation Market Application Movement Analysis
• 7.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by Application, 2021 - 2033 (USD Million)
• 7.4. Drug & Biomarker Discovery
  • 7.4.1. Drug & Biomarker Discovery Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 7.5. Disease Diagnostics
  • 7.5.1. Disease Diagnostics Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
  • 7.5.2. Cancer Diagnostics
    • 7.5.2.1. Cancer Diagnostics Market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Reproductive Health Diagnostics
    • 7.5.3.1. Reproductive Health Diagnostics Market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Infectious Disease Diagnostics
    • 7.5.4.1. Infectious Disease Diagnostics Market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Other Disease Diagnostic Applications
    • 7.5.5.1. Other Disease Diagnostic Applications Market estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)

Chapter 8. Automated NGS Library Preparation Market: End Use Estimates & Trend Analysis

• 8.1. End Use Segment Dashboard
• 8.2. Global Automated NGS Library Preparation Market End Use Movement Analysis
• 8.3. Global Automated NGS Library Preparation Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
• 8.4. Hospitals and Clinics
  • 8.4.1. Hospitals and Clinics Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 8.5. Academic and Research Institutions
  • 8.5.1. Academic and Research Institutions Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 8.6. Pharmaceutical and Biotechnology Companies
  • 8.6.1. Pharmaceutical and Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)
• 8.7. Others
  • 8.7.1. Others Market Size & Forecasts and Trend Analyses, 2021 - 2033 (USD Million)

Chapter 9. Automated NGS Library Preparation Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2021 & 2033
• 9.2. Regional Market Dashboard
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Mexico
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework
    • 9.3.3.3. Competitive scenario
    • 9.3.3.4. Mexico market estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Argentina market estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Participant Categorization
• 10.2. Company Market Position Analysis, 2025
• 10.3. Strategy Mapping
• 10.4. Participants Overview
  • 10.4.1. Illumina, Inc.
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Thermo Fisher Scientific Inc.
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Agilent Technologies, Inc.
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. QIAGEN N.V.
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. F. Hoffmann-La Roche Ltd
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Bio-Rad Laboratories, Inc.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Revvity, Inc.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Oxford Nanopore Technologies Ltd.
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Pacific Biosciences of California, Inc.
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Hamilton Company
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives